Results 191 to 200 of about 204,414 (356)

Significance of androgen receptor and its potential for anti-androgen/androgen receptor-antagonist therapy in ovarian cancers. [PDF]

PLoS One
Kim TH, Memarzadeh S, Vahdatshariatpanahi S, Ostrzega N, Kang Y, Moatamed NA.   +5 more
europepmc   +1 more source

CTHRC1 promotes bone metastasis in prostate cancer

International Journal of Cancer, EarlyView.
What's New? The mechanisms driving bone metastasis in prostate cancer are still unclear, and predicting markers have not yet been identified. Based on the biological characterization of prostate cancer cell lines and integrated data analysis of clinical samples, the authors identified CTHRC1 as a candidate gene regulating prostate cancer bone ...
Yuichiro Sawada, Tadahiko Kikugawa, Tomoya Onishi, Osuke Arai, Hiroyuki Iio, Noriyoshi Miura, Shuhei Yoshida, Aoi Ikedo, Yuta Yanagihara, Noritaka Saeki, Iori Sakakibara, Balázs Győrffy, Takeshi Kishida, Yoichiro Okubo, Yoshiyasu Nakamura, Shinya Sato, Yohei Miyagi, Takashi Saika, Yuuki Imai   +18 more
wiley   +1 more source

Polyglutamine expansion induced dynamic misfolding of androgen receptor. [PDF]

Protein Sci
Heling LWHJ, Sheikhhassani V, Ng J, van Vliet M, Jiménez-Panizo A, Alegre-Martí A, Woodard J, van Roon-Mom W, McEwan IJ, Estébanez-Perpiñá E, Mashaghi A.   +10 more
europepmc   +1 more source

Androgenic regulation of ornithine decarboxylase activity in mouse kidney and its relationship to changes in cytosol and nuclear androgen receptor concentrations.

, 1982
Antti Pajunen, Veli Isomaa, Olli A. Jänne, C. Wayne Bardin   +3 more
openalex   +1 more source

Clinical impact of real‐time androgen receptor alteration monitoring on metastatic castration‐resistant prostate cancer treatment in real‐world settings

International Journal of Cancer, EarlyView.
What's New? Androgen receptor (AR) alterations contribute to treatment resistance against androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer. This real‐world study demonstrates that AR monitoring via liquid biopsy predicts treatment response and progression in metastatic castration‐resistant prostate cancer.
Regina Stitz, Franz Stoiber, Renè Silye, Elisabeth Rebhan, Michael Dunzinger, Franz Pühringer, Ellen Heitzer, Cornelia Hauser‐Kronberger   +7 more
wiley   +1 more source

Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine Therapies. [PDF]

Res Rep Urol
Quistini A, Chierigo F, Fallara G, Depalma M, Tozzi M, Maggi M, Jannello LMI, Pellegrino F, Mantica G, Terracciano D, Papalia R, Crocetto F, Damiano R, Bianchi R, Rocco BM, Ferro M.   +15 more
europepmc   +1 more source

Circadian rhythm of hepatic cytosolic and nuclear estrogen and androgen receptors

, 1986
A. Francavilla, Patricia K. Eagon, Alfredo Di Leo, David H. Van Thiel, Carmine Panella, Lorenzo Polimeno, Cinzia Amoruso, Marcello Ingrosso, AM Aquilino, Thomas E. Starzl   +9 more
openalex   +1 more source

Effects of Exogenous Steroids on Androgen Receptors in Fetal Guinea Pig Brain1 [PDF]

, 1991
Karen T. Toyooka, Peter B. Connolly, John A. Resko   +2 more
openalex   +1 more source

TMB‐High, MSI‐High Castration‐Resistant Prostate Cancer Treated With Pembrolizumab

IJU Case Reports, EarlyView.
ABSTRACT Introduction The use of pembrolizumab in patients with microsatellite instability‐high (MSI‐high) and tumor mutation burden‐high (TMB‐high) prostate cancer in Japan is not widely reported. Here, we report the case of a patient with MSI‐high and TMB‐high prostate cancer who responded well to pembrolizumab after multiple systemic treatments ...
Satoshi Muraoka, Hisanobu Tosuji, Yuya Iwahashi, Hiroki Kawabata, Ryusuke Deguchi, Takahito Wakamiya, Shimpei Yamashita, Yasuo Kohjimoto, Isao Hara   +8 more
wiley   +1 more source

Androgen and Androgen Receptor in Kidney Cancer [PDF]

Nephrology - Open Journal, 2015
Joshua Cho, Kouji Izumi, Chiung-Kuei Huang   +2 more
openaire   +1 more source